Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa J Crawford

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancers|August 1, 2020
TIF1 Proteins in Genome Stability and CancerRoisin M McAvera, Lisa J Crawford
Blood Reviews|November 5, 2013
Targeting the ubiquitin proteasome system in haematological malignanciesLisa J Crawford, Alexandra E Irvine
Cancers|June 2, 2021
The Ubiquitin Proteasome System in Genome Stability and CancerJonathan J Morgan, Lisa J Crawford
Methods in Molecular Biology (Clifton, N.J.)|October 14, 2016
Separation and Enrichment of Hematopoietic Stem Cells for CCN StudiesLisa J Crawford, Alexandra E Irvine
Journal of Cell Communication and Signaling|April 13, 2011
Proteasome inhibitors in cancer therapyLisa J Crawford, Brian Walker, Alexandra E Irvine
International Journal of Molecular Sciences|February 10, 2019
TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal CellsJonathan J Morgan, Roisin M McAvera, Lisa J Crawford
Journal of Cell Communication and Signaling|November 8, 2017
TRIM proteins in blood cancersLisa J Crawford, Cliona K Johnston, Alexandra E Irvine
Oncotarget|September 23, 2016
Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myelomaLisa J Crawford, Gordon Anderson, Cliona K Johnston, et al.
Scientific Reports|April 16, 2024
TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitorsRoisin M McAvera, Jonathan J Morgan, Ana B Herrero, et al.
The Journal of Pathology|December 6, 2013
The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemiaSukanya Suresh, Lynn McCallum, Lisa J Crawford, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancers|August 1, 2020
TIF1 Proteins in Genome Stability and CancerRoisin M McAvera, Lisa J Crawford
Blood Reviews|November 5, 2013
Targeting the ubiquitin proteasome system in haematological malignanciesLisa J Crawford, Alexandra E Irvine
Cancers|June 2, 2021
The Ubiquitin Proteasome System in Genome Stability and CancerJonathan J Morgan, Lisa J Crawford
Methods in Molecular Biology (Clifton, N.J.)|October 14, 2016
Separation and Enrichment of Hematopoietic Stem Cells for CCN StudiesLisa J Crawford, Alexandra E Irvine
Journal of Cell Communication and Signaling|April 13, 2011
Proteasome inhibitors in cancer therapyLisa J Crawford, Brian Walker, Alexandra E Irvine
International Journal of Molecular Sciences|February 10, 2019
TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal CellsJonathan J Morgan, Roisin M McAvera, Lisa J Crawford
Journal of Cell Communication and Signaling|November 8, 2017
TRIM proteins in blood cancersLisa J Crawford, Cliona K Johnston, Alexandra E Irvine
Oncotarget|September 23, 2016
Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myelomaLisa J Crawford, Gordon Anderson, Cliona K Johnston, et al.
Scientific Reports|April 16, 2024
TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitorsRoisin M McAvera, Jonathan J Morgan, Ana B Herrero, et al.
The Journal of Pathology|December 6, 2013
The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemiaSukanya Suresh, Lynn McCallum, Lisa J Crawford, et al.
Pageof 2